Results 41 to 50 of about 26,607 (119)

Bilateral Atypical Femur Fracture in a Patient Under Bisphosphonate Treatment

open access: yesEndocrinology Research and Practice, 2019
Osteoporosis is a systemic skeletal disease that affects most of the elderly people. Bisphosphonate is an effective anti-resorptive drug widely used for the prevention and treatment of osteoporosis.
Duygu ŞİLTE KARAMANLIOĞLU   +4 more
doaj  

Structure-Dependent Effects of Bisphosphonates on Inflammatory Responses in Cultured Neonatal Mouse Calvaria

open access: yesAntioxidants, 2020
Bisphosphonates (BPs) are classified into two groups, according to their side chain structures, as nitrogen-containing BPs (NBPs) and non-nitrogen-containing BPs (non-NBPs).
Keiko Suzuki   +6 more
doaj   +1 more source

Role of Teriparatide in Medication-Related Osteonecrosis of the Jaws (MRONJ)

open access: yesDentistry Journal, 2016
While the optimal treatment concept of medication-related osteonecrosis of the jaws (MRONJ) is still in debate, several adjunct therapies have been introduced.
Yong-Dae Kwon, Deog-Yoon Kim
doaj   +1 more source

Preparation, Characterization, and Radiolabeling of [68Ga]Ga-NODAGA-Pamidronic Acid: A Potential PET Bone Imaging Agent

open access: yesMolecules, 2020
Early diagnosis of bone metastases is crucial to prevent skeletal-related events, and for that, the non-invasive techniques to diagnose bone metastases that make use of image-guided radiopharmaceuticals are being employed as an alternative to traditional
Zarif Ashhar   +8 more
doaj   +1 more source

Validation and Feasibility of the Medication Acceptability Questionnaire to Investigate Tablet and Liquid Alendronic Acid with Older Hospital Patients

open access: yesPharmacy, 2018
The effects of formulation characteristics on acceptability are poorly understood. This study evaluated the validity and feasibility of using the Medication Acceptability Questionnaire (MAQ) to investigate factors influencing acceptability of tablet ...
Sion Scott   +3 more
doaj   +1 more source

Prevalence of Medication-Related Osteonecrosis of the Jaw in Patients with Breast Cancer, Prostate Cancer, and Multiple Myeloma

open access: yesDentistry Journal, 2016
Medication-related osteonecrosis of the jaw is a known side-effect of antiresorptive therapy in patients with malignant diseases. Nevertheless, the exact pathogenesis is still unknown and published prevalences show a significant range.
Petra Rugani   +5 more
doaj   +1 more source

Time since last intravenous bisphosphonate and risk of osteonecrosis of the jaw in osteoporotic patients

open access: yesNature Communications
Medication-related osteonecrosis of the jaw is a rare but serious condition in which the jawbone fails to heal and becomes necrotic, typically after dental surgery in patients treated with bisphosphonates.
Jung-Hyun Park   +6 more
doaj   +1 more source

Spectrum of activity and mechanisms of azole–bisphosphonate synergy in pathogenic Candida

open access: yesMicrobiology Spectrum
Candidiasis places a significant burden on human health and can range from common superficial vulvovaginal and oral infections to invasive diseases with high mortality.
Aidan Kane   +5 more
doaj   +1 more source

Prosthodontic care and management of patients with MRONJ from different microbiological backgrounds

open access: yesFogorvosi Szemle
Medication-related osteonecrosis of the Jaw (MRONJ) is a severe condition of multifactorial origin, with its exact etiological factors still not fully understood.
Flóra Alíz Lakatos   +5 more
doaj   +1 more source

Skin involvement of medication-related osteonecrosis of jaws in an immunocompromised, bisphosphonate-treated patient

open access: yesJAAD Case Reports, 2022
Ye Eun Kim, MD   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy